Daniel S. Raccuia, Pharmd Candidate, L. Holle, Pharmd, Bcop, Fhopa
{"title":"FDA批准诺瑞匹坦预防化疗引起的恶心和呕吐","authors":"Daniel S. Raccuia, Pharmd Candidate, L. Holle, Pharmd, Bcop, Fhopa","doi":"10.1211/pj.2015.20069288","DOIUrl":null,"url":null,"abstract":"Rolapitant is a novel NK1 receptor antagonist that maintains >90% receptor binding up to five days after a single 180-mg dose.","PeriodicalId":12354,"journal":{"name":"Formulary","volume":"71 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2016-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"FDA approves rolapitant to prevent chemotherapy-induced nausea and vomiting\",\"authors\":\"Daniel S. Raccuia, Pharmd Candidate, L. Holle, Pharmd, Bcop, Fhopa\",\"doi\":\"10.1211/pj.2015.20069288\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Rolapitant is a novel NK1 receptor antagonist that maintains >90% receptor binding up to five days after a single 180-mg dose.\",\"PeriodicalId\":12354,\"journal\":{\"name\":\"Formulary\",\"volume\":\"71 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-06-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Formulary\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1211/pj.2015.20069288\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Formulary","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1211/pj.2015.20069288","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
